{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:28:59Z","timestamp":1787574539427,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","funder":[{"name":"Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation and Clinical Impact at Stanford University"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate cabergoline's efficacy at decreasing lactation symptoms after early second-trimester abortion or pregnancy loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This is a multisite, double-blind, gestational-age stratified superiority trial that compared cabergoline 1 mg once with placebo for preventing bothersome breast symptoms immediately after uterine evacuation. We enrolled pregnant people at 16\u201320 weeks of gestation who were English- or Spanish-speaking and without contraindication to the study drug. Participants received cabergoline within 4 hours of uterine evacuation or fetal expulsion and, at baseline and at multiple time points through 2 weeks postprocedure, completed a validated electronic survey that assessed breast symptoms, side effects, and bother. Our primary outcome was breast symptoms (a composite of engorgement, milk leakage, tenderness, and need for pain relief) on day 4; we planned to enroll 30 participants in each gestational duration strata to show a 40% difference in breast symptoms (80% power, \u03b1=0.049).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      After screening 145 patients from February 2024 through May 2025, we enrolled 69 eligible participants. Baseline demographics were balanced between groups: Median gestational duration was 18 weeks (range 16 0\/7\u201319 6\/7 weeks), 53.0% were nulliparous, 63.6% self-identified as Hispanic, and 68.2% had public insurance. On day 4, significantly fewer participants who received cabergoline reported any breast symptoms compared with placebo (50.0% vs 88.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001) (primary outcome) and fewer participants reported significant bother from breast symptoms (3.1% vs 20.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.05) (secondary outcome). These differences persist even in the earlier gestational duration strata.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Cabergoline is an effective and well-tolerated medication to prevent breast symptoms after early second-trimester abortion or pregnancy loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov: NCT06029673.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006137","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:00:28Z","timestamp":1768514428000},"page":"277-284","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cabergoline for Lactation Inhibition After Early Second-Trimester Abortion or Pregnancy Loss"],"prefix":"10.1097","volume":"147","author":[{"given":"Andrea","family":"Henkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica P.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade M.","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie I.","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranvir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amythis","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiyah","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Mastey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre J.","family":"Lyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"R1-20260824","first-page":"305","article-title":"The nuts and bolts of breastfeeding: anatomy and physiology of lactation","volume":"47","author":"Sriraman","year":"2017","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-030-41596-9_1","article-title":"Anatomy and physiology of the breast during pregnancy and lactation","volume":"1252","author":"Alex","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.ajog.2023.10.025","article-title":"The experience of breast symptoms after second-trimester abortion or pregnancy loss","volume":"230","author":"Henkel","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"53876","DOI":"10.5539\/gjhs.v8n9p234","article-title":"An exploration of the maternal experiences of breast engorgement and milk leakage after perinatal Loss","volume":"8","author":"Sereshti","year":"2016","journal-title":"Glob J Health Sci"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jogc.2019.03.014","article-title":"Safety of cabergoline for postpartum lactation inhibition or suppression: a systematic review","volume":"42","author":"Harris","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmjsrh-2024-202438","article-title":"Management of breast engorgement after second-trimester abortion or loss: a survey of current practice patterns","volume":"51","author":"Henkel","year":"2025","journal-title":"BMJ Sex Reprod Health"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/AOG.0000000000005190","article-title":"Cabergoline for lactation inhibition after second-trimester abortion or pregnancy loss: a randomized controlled trial","volume":"141","author":"Henkel","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"110143, 00726-3","DOI":"10.1016\/j.contraception.2023.110143","article-title":"Society of family planning clinical recommendation: medication abortion between 14 0\/7 and 27 6\/7 weeks of gestation: jointly developed with the society for maternal-fetal medicine","volume":"129","author":"Zwerling","year":"2024","journal-title":"Contraception"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Methods for estimating the due date. Committee Opinion No 700. American College of Obstetricians and Gynecologists","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0001-6349.2004.00315.x","article-title":"Ultrasound estimates of gestational age among perinatally demised: a population-based study","volume":"83","author":"Olsen","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006199-196601530-00004","article-title":"Comparative effectiveness of compressional and supporting breast binders in suppressing lactation","volume":"15","author":"Bristol","year":"1966","journal-title":"Nurs Res"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/epirev\/24.1.39","article-title":"Sample size calculations for randomized controlled trials","volume":"24","author":"Wittes","year":"2002","journal-title":"Epidemiol Rev"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029900800102","article-title":"Multiple imputation: a primer","volume":"8","author":"Schafer","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1097\/01.AOG.0000664260.95519.2e","article-title":"Breast symptoms after pregnancy loss and abortion: an observational study [abstract 03J]","volume":"135","author":"Hagey","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R17-20260824","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale J Biol Med"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2265.1992.tb01485.x","article-title":"Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European multicentre cabergoline dose-finding study group","volume":"37","author":"Webster","year":"1992","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:05:39Z","timestamp":1787573139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006137"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006137","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}